Eutilex.Co.,Ltd (KOSDAQ:263050)
South Korea · Delayed Price · Currency is KRW 959.00
+221.00 (29.95%)
At close: Feb 6, 2026
Eutilex.Co.,Ltd Market Cap
Eutilex.Co.,Ltd has a market cap or net worth of 35.32 billion as of October 16, 2026. It is the 34,968th most valuable company in the world and the 2,043rd biggest in South Korea. Its market cap has decreased by 48.77% in one year.
Market Cap
35.32B
Enterprise Value
45.79B
Revenue
7.71B
Global Rank
Country Rank
#2,043 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since December 24, 2018, Eutilex.Co.,Ltd's market cap has decreased from 567.29B to 35.32B, a decrease of -93.77%. That is a compound annual growth rate of -32.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 35.32B | -13.45% |
| Dec 30, 2025 | 40.81B | -42.41% |
| Dec 30, 2024 | 70.86B | -42.97% |
| Dec 28, 2023 | 124.25B | -49.10% |
| Dec 29, 2022 | 244.11B | -29.44% |
| Dec 30, 2021 | 345.97B | -38.90% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 24, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| KoBioLabs | 54.57B |
| TegoScience | 53.64B |
| NovMetaPharma | 53.10B |
| J2KBIO | 50.87B |
| QuadMedicine | 48.22B |
| Parataxis Korea | 44.13B |
| Epibiotech | 43.62B |
| HLB Pep | 40.51B |